AHL Partners’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-38,473
Closed -$1.44M 1404
2017
Q3
$1.44M Sell
38,473
-42,647
-53% -$1.51M 0.03% 769
2017
Q2
$3.02M Sell
81,120
-86,384
-52% -$3.12M 0.06% 516
2017
Q1
$6.57M Buy
167,504
+125,913
+303% +$4.72M 0.15% 244
2016
Q4
$1.45M Sell
41,591
-18,229
-30% -$716K 0.04% 580
2016
Q3
$2.35M Sell
59,820
-18,877
-24% -$753K 0.09% 330
2016
Q2
$2.97M Buy
78,697
+69,257
+734% +$2.32M 0.16% 152
2016
Q1
$362K Sell
9,440
-1,477
-14% -$55K 0.02% 634
2015
Q4
$525K Buy
+10,917
New +$505K 0.04% 454

Other funds holding NTUS

AHL Partners's NTUS Position: Q4 2017 in Review

AHL Partners sold out of Natus Medical Inc (NTUS) in Q4 2017, closing a stake of 38,473 shares — an estimated $1.44M sold.

AHL Partners first reported a position in NTUS in Q4 2015 and held it in 8 quarters. The position peaked at $6.57M in Q1 2017. 214 funds tracked by Wall St. Rank hold NTUS as of Q4 2017.

  • AHL Partners reported no remaining Natus Medical Inc position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 38,473 Natus Medical Inc shares in Q4 2017, an estimated $1.44M.
  • AHL Partners first reported a position in Natus Medical Inc in Q4 2015 and held it in 8 quarters.
  • AHL Partners's Natus Medical Inc position peaked at $6.57M in Q1 2017.
  • 214 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.